What is it about?
To measure the efficacy and safety of simultaneous administration of Dexamethasone, Lidocaine, and Thiamine to the trigeminal nerve branches as well as greater and lesser occipital nerve in chronic migraine, craniofacial neuralgia.
Featured Image
Why is it important?
A simultaneous treatment of trigeminal and occipital nerves bilaterally never been studied. Interestingly, combination of Thiamine, Lidocaine, and Dexamethasone as genetic signaling modifier did not reveal any utilization in treatment of chronic migraine or trigeminal neuralgia ever.
Perspectives
Nine years of experiences (2006-2016) with De-Novo formula demonstrated that its components are safe, and efficient if administered simultaneously and bilaterally. DE-NOVO algorithm in treatment of chronic migraine and trigeminal neuralgia is less aggressive, less costly, safer, and demonstrates longer pain relief. In addition, De-Novo components are widely available, inexpensive, and administration is safe and practical by all medical specialties with minimal training. Overall seen there are over 50 different medical modalities in treatment of migraine worldwide available. Diet and supplemental, biofeedback, hypnotic and tribal shamanic regional modalities not included. Respecting the dignity of healthy life for human kind shows that De-Novo” treatment and formula provides longer relief of migraine with one treatment session in 95% to 98% of cases including chronic cluster headaches than any other current modalities
Dr Faro T Owiesy
Corona doctors Medical Clinics
Read the Original
This page is a summary of: European Journal of Neurology, European Journal of Neurology, December 2000, Wiley,
DOI: 10.1111/j.1468-1331.2000.00005.x.
You can read the full text:
Resources
Contributors
The following have contributed to this page
